Skip to main content
Oncotarget logoLink to Oncotarget
. 2018 Oct 30;9(85):35599. doi: 10.18632/oncotarget.26304

Correction: Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells

Vojtech Novohradsky 1, Juraj Zajac 1, Oldrich Vrana 1, Jana Kasparkova 1, Viktor Brabec 1
PMCID: PMC6238977  PMID: 30473754

This article has been corrected: The correct Grant information is given below:

ACKNOWLEDGMENTS

This work was supported by the Czech Science Foundation, Grant No. 18-09502S. The authors thank to Dr. Klára Čépe, Dr. Václav Ranc and Zuzana Chaloupková from the Regional Centre of Advanced Technologies and Materials (Olomouc, Czech Republic) for the TEM, DLS and ξ-potential analysis.

Original article: Oncotarget. 2018; 9:28456-28473. https://doi.org/10.18632/oncotarget.25466


Articles from Oncotarget are provided here courtesy of Impact Journals, LLC

RESOURCES